FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

33614011000001105: Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2137961000001119 Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2137971000001112 Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Is a Repaglinide 500microgram tablets 30 tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has AMP Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has excipient Butylated hydroxyanisole false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has specific active ingredient Repaglinide true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start